Lung Cancer Screening with Low-Dose CT: What We Have Learned in Two Decades of ITALUNG and What Is Yet to Be Addressed

Lung Cancer Screening with Low-Dose CT: What We Have Learned in Two Decades of ITALUNG and What Is Yet to Be Addressed

The ITALUNG trial started in 2004 and compared lung cancer (LC) and other-causes mortality in 55–69 years-aged smokers and ex-smokers who were randomized to four annual chest low-dose CT (LDCT) or usual care. ITALUNG showed a lower LC and cardiovascular mortality in the screened subjects after 13 ye...

Full description

Bibliographic Details
Main Authors: Mario Mascalchi, Giulia Picozzi, Donella Puliti, Stefano Diciotti, Annalisa Deliperi, Chiara Romei, Fabio Falaschi, Francesco Pistelli, Michela Grazzini, Letizia Vannucchi, Simonetta Bisanzi, Marco Zappa, Giuseppe Gorini, Francesca Maria Carozzi, Laura Carrozzi, Eugenio Paci
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Diagnostics
Subjects:
biomarkers
coronary artery calcifications
emphysema
low-dose CT
lung cancer
lung nodules
Online Access:https://www.mdpi.com/2075-4418/13/13/2197

Internet

https://www.mdpi.com/2075-4418/13/13/2197

Similar Items